Hellenic Center for Disease Control & Prevention


Office for Viral Hepatitis
Chronic viral hepatitis caused by hepatitis B and C viruses constitutes a major problem for world-wide public health.
Viral hepatitis B and C:
a)    affect a large part of the population
b)    are transferred from person to person
c)    are associated with significant morbidity and mortality
d)    require specialized curative intervention.

In our country, the prevalence of chronic hepatitis B is estimated to 2.5–3% of the population, and hepatitis C 1.5–2% of the population, although the incidence of chronic viral hepatitis varies per geographic department and population. The main effects on public health are increased morbidity and mortality of patients from liver disease and the transmission of the viruses within the social environment. As is well known, a significant percentage of patients with chronic hepatitis B or C infection are associated with complications of chronic infection, such as liver cirrhosis, hepatocellular carcinoma (HCC), liver failure and death, if they are not monitored and do not receive specific antiviral therapy.
Hepatitis B virus is transmitted by sexual contact, parenterally (i.v., i.m. and s.c.) and from a mother with HBsAg(+) to a child during pregnancy or childbirth (vertical transmission).
Hepatitis C virus is mainly transmitted by parenteral contact and rarely through sexual contact or vertical transmission from mother to child. The potential of therapeutic intervention for chronic hepatitis B and C has improved significantly  in recent years.
The Hellenic Center for Disease Control and Prevention (HCDCP) Office for Viral Hepatitis has been in operation since 2000 and deals with:
· prevention of viral hepatitis transmission
· protection of public health
· promotion of vaccination
· improvement of clinical care for people who suffer from viral hepatitis B and C

· epidemiological surveillance of chronic hepatitis B and C through study of the national viral hepatitis cohort of the HCDCP.  

The general public, health professionals and high-risk groups can obtain information about the modes of transmission, prevention and treatment:  
· by telephone (office hours 8.00–15.30)
· from information brochures
· by arranging talks for organizations, institutions and communities
· from articles published in newspapers and magazines
· from the active involvement of the office’s staff in educational seminars for appropriate communities, e.g. informing inmate relatives, staff, schools, clubs, institutions and organizations
· from HCDCP website, which is continually updated and renewed.                                                              
HCDCP | Structure / Function | Call for tenders | Programs | Available Material | Useful Links | Contact Us
Copyright (c) 2018 HCDCP - Design & Development by SDC S.A.